About STADA Pymepharco
STADA Pymepharco has officially become the sole wholly affiliate member of STADA Group (Germany) in Vietnam since 2021.
As one of the leading pharmaceutical manufacturers in Vietnam, STADA Pymepharco is committed to providing 'German standard' pharmaceutical products with international quality and reasonable prices:
2 EU-GMP plants
in Tuy Hoa, Dak Lak – each with an annual production capacity of nearly 1.2 billion units,
plus an additional 20–40 million finished packs per year
400+ products
in Vietnam – including 250 Generics and 150 Consumer Healthcare products, with 80 assessed as bioequivalent to innovator medicines
1,000+ employees
working across manufacturing sites and offices in Ho Chi Minh City and Tuy Hoa, Dak Lak – alongside a nationwide sales force
14,000+ customers
nationwide, including hospitals, medical facilities, pharmacies, pharmacy chains and other pharmaceutical businesses
2024 - Present
09–2024
06–2024
2023
2021
2019
2018
2013
2008
2005 – 2008
2003
2001
1989
2024 - Present
- STADA Pymepharco announced its new corporate positioning and refreshed brand identity.
- The company continues to expand partnerships, scale up production, and invest in advanced technologies – not only to meet domestic demand but also to drive exports globally, with a particular focus on the European market.
09–2024
- STADA Pymepharco celebrated its 35th anniversary on September 26, 2024, in Tuy Hoa Ward, Dak Lak Province (formerly known as Phu Yen Province).
- At the ceremony, the company was honored to receive Certificates of Merit from the Minister of Health and the Phu Yen Department of Health, recognizing 35 years of dedicated contribution to public healthcare.
06–2024
- STADA Pymepharco proudly exported the first batch of pharmaceuticals manufactured in Vietnam to the European market.
2023
- The company’s second manufacturing site (PME-2 or STADA Vietnam) officially received its first EU-GMP certification for the Non-betalactam solid dosage area.
- The first manufacturing site (PME-1 or Pymepharco) successfully renewed its EU-GMP certification for both the solid and injectable Betalactam production lines.
2021
- Officially became the sole wholly affiliate member of STADA Group (Germany) in Vietnam in 2021.
- The company has since gradually developed under the name STADA Pymepharco, aiming toward global standards in healthcare.
2019
- The second manufacturing site (PME-2 or STADA Vietnam) commenced operations with an annual capacity of 1.2 billion units.
2018
- Received its first EU-GMP certification for Betalactam injectables by the European Medicines Agency of the Federal Republic of Germany.
2013
- The first pharmaceutical manufacturer in Vietnam to receive EU-GMP certification for Betalactam tablets – with EU-GMP is the highest standard in pharmaceutical manufacturing.
2008
- STADA Group (Germany) became a strategic shareholder in Pymepharco by acquiring a 51% ownership stake.
2005 – 2008
- The injectable pharmaceutical manufacturing plant began construction in 2005.
- By 2008, the sterile drug facility was certified with GMP-WHO by the Ministry of Health (Vietnam).
2003
- The first manufacturing site (PME-1) received GMP and GLP certifications for tablet forms & officially commenced operations with 03 production lines.
2001
Groundbreaking ceremony for the first pharmaceutical manufacturing site.
1989
- Established in 1989 as Pymepharco, focusing on supplying pharmaceuticals and medical equipment, as well as cultivating and sourcing medicinal herbs.
